| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.56B | 10.22B | 9.17B | 8.49B | 7.89B | 7.19B |
| Gross Profit | 7.98B | 7.82B | 7.37B | 6.79B | 6.22B | 5.38B |
| EBITDA | 5.90B | 5.20B | 4.94B | 4.24B | 3.81B | 3.15B |
| Net Income | 3.58B | 3.49B | 3.26B | 2.86B | 2.46B | 2.00B |
Balance Sheet | ||||||
| Total Assets | 30.73B | 33.01B | 30.11B | 28.00B | 25.26B | 22.57B |
| Cash, Cash Equivalents and Short-Term Investments | 12.20B | 16.62B | 15.84B | 17.53B | 18.50B | 16.06B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.98B | 6.62B | 5.98B | 6.00B | 5.54B | 5.38B |
| Stockholders Equity | 22.73B | 24.36B | 22.34B | 20.51B | 18.31B | 16.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.97B | 2.92B | 2.73B | 2.56B | 4.62B |
| Operating Cash Flow | 0.00 | 4.10B | 3.13B | 3.24B | 2.66B | 4.69B |
| Investing Cash Flow | 0.00 | 311.33M | -4.28B | -4.19B | -1.82B | -80.17M |
| Financing Cash Flow | 0.00 | -1.44B | -1.33B | -713.10M | -87.53M | 2.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥79.11B | 21.69 | ― | 2.02% | 11.65% | 10.43% | |
81 Outperform | ¥24.54B | 17.71 | ― | 2.50% | 15.18% | 25.18% | |
69 Neutral | ¥426.93B | 16.35 | 14.42% | 4.80% | 9.59% | 12.35% | |
68 Neutral | ¥43.08B | 20.82 | ― | ― | 10.59% | 203.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥3.13B | 3.97 | ― | 2.04% | 13.92% | -31.66% | |
56 Neutral | ¥74.90B | 12.85 | ― | 2.44% | 13.66% | -17.71% |